BYU ScholarsArchive
metadata only
Applying Ceragenins in Translational Medicine: Activating Mesenchymal Stem Cells and Preventing Healthcare-Associated Infections
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Isotretinoin in Treatment of COVID-19#893563
- Fase I Clinical Trial on NK Cells for COVID-19#390958
- Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis#1044271
- EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE#152454
- Regulatory T cell therapies: biological foundations, engineering strategies, and clinical translation#257538
Record · ID 314211
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive